SCHEMBL3283250

SCHEMBL3283250

c1ccc(-c2ccc(-c3ccccc3-c3nnco3)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 13/20 0.66
▸ TLR8 Q9NR97 1/20 0.53
▸ KMT2A Q03164 1/20 0.48
▸ NPC1 O15118 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ GPR55 Q9Y2T6 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4276979 0.96 NOTUM (0.70) NOTUMTLR8KMT2ANPC1TP53
SCHEMBL27854127 0.86 NOTUM (0.54) NOTUMTLR8KMT2ANPC1TP53
SCHEMBL5571187 0.84 NOTUM (0.91) NOTUMTLR8TSHRALDH1A1
Biphenyl SCHEMBL22577775 0.82 NOTUM (0.95) NOTUMTLR8NPC1TSHRRAB9A
SCHEMBL9641641 0.81 NOTUM (0.66) NOTUMTLR8KMT2ANPC1TP53
SCHEMBL9555 0.80 NOTUM (1.00) NOTUMTLR8NPC1TSHRRAB9A
SCHEMBL7917146 0.79 NOTUM (0.49) NOTUMTLR8NPC1TP53TSHR
SCHEMBL9341647 0.78 NOTUM (0.56) NOTUMTLR8NPC1TP53TSHR
SCHEMBL15392075 0.76 NOTUM (0.45) NOTUMTLR8KMT2ANPC1TP53
SCHEMBL6190865 0.76 NOTUM (0.59) NOTUMTLR8KMT2ANPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010045529-A1 Double-resonance-absorption microscope OLYMPUS CORPORATION (JP) 2001-11-29 — — US claimed
US-20200174008-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION 2020-06-04 — — US disclosed
US-10436790-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals WATERS TECHNOLOGIES CORPORATION (US) 2019-10-08 — — US disclosed
US-20140350263-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS WATERS TECHNOLOGIES CORPORATION (US) 2014-11-27 — — US disclosed
US-8847479-B2 Organic electroluminescent lighting system including wiring including a plurality of openings SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-09-30 — — US disclosed
US-20100025716-A1 LIGHTING SYSTEM SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2010-02-04 — — US disclosed
US-6844963-B2 Double-resonance-absorption microscope OLYMPUS OPTICAL CO., LTD. (JP) 2005-01-18 — — US disclosed
US-6667830-B1 Super-resolution microscope system and method for illumination JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2003-12-23 — — US disclosed
US-20010045529-A1 Double-resonance-absorption microscope OLYMPUS CORPORATION (JP) 2001-11-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140350263-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS FUT5, FUT6, CSGALNACT1 NOTUM 2591/4885TLR8 2379/4885KMT2A 3081/4885
US-20200174008-A1 RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS FUT5, FUT6, CSGALNACT1 NOTUM 2591/4885TLR8 2379/4885KMT2A 3081/4885
US-10436790-B2 Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals FUT5, FUT6, CSGALNACT1 NOTUM 3692/4885TLR8 3523/4885KMT2A 2419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback